Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic
-
Published:2022-10-14
Issue:2
Volume:149
Page:913-919
-
ISSN:0171-5216
-
Container-title:Journal of Cancer Research and Clinical Oncology
-
language:en
-
Short-container-title:J Cancer Res Clin Oncol
Author:
Arndt VolkerORCID, Doege DanielaORCID, Fröhling StefanORCID, Albers PeterORCID, Algül HanaORCID, Bargou RalfORCID, Bokemeyer CarstenORCID, Bornhäuser MartinORCID, Brandts Christian H.ORCID, Brossart Peter, Brucker Sara YvonneORCID, Brümmendorf Tim H.ORCID, Döhner HartmutORCID, Gattermann NorbertORCID, Hallek MichaelORCID, Heinemann VolkerORCID, Keilholz UlrichORCID, Kindler ThomasORCID, von Levetzow Cornelia, Lordick FlorianORCID, Neumann Ulf PeterORCID, Peters Christoph, Schadendorf DirkORCID, Stilgenbauer StephanORCID, Zander ThomasORCID, Zips DanielORCID, Braun DeliaORCID, Seufferlein ThomasORCID, Nettekoven Gerd, Baumann MichaelORCID
Abstract
Abstract
Purpose
An increasing number of international studies demonstrate serious negative effects of the COVID-19 pandemic on the timely diagnosis of cancer and on cancer treatment. Our study aimed to quantitatively and qualitatively evaluate the capacities of German Comprehensive Cancer Centers (CCCs) in different areas of complex oncology care during the first 2 years of the COVID-19 pandemic.
Methods
Prospective panel survey over 23 rounds among 18 CCCs in Germany between March 2020 and June 2022.
Results
The COVID-19 pandemic substantially affected the oncological care system in Germany during the first 2 years. Persistent limitations of care in CCCs primarily affected follow-up (− 21%) and psycho-oncologic care (− 12%), but also tumor surgery (− 9%). Substantial limitations were also reported for all other areas of multidisciplinary oncological care.
Conclusions
This study documents the limitations of oncological care during the COVID-19 pandemic and highlights the need to develop strategies to avoid similar limitations in the future.
Funder
Deutsches Krebsforschungszentrum (DKFZ)
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference23 articles.
1. Aapro M, Lyman GH, Bokemeyer C, Rapoport BL, Mathieson N, Koptelova N, Cornes P, Anderson R, Gascon P, Kuderer NM (2021) Supportive care in patients with cancer during the COVID-19 pandemic. ESMO Open 6:100038. https://doi.org/10.1016/j.esmoop.2020.100038 2. Dinmohamed AG, Cellamare M, Visser O, de Munck L, Elferink MAG, Westenend PJ, Wesseling J, Broeders MJM, Kuipers EJ, Merkx MAW, Nagtegaal ID, Siesling S (2020a) The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in the Netherlands. J Hematol Oncol 13:147. https://doi.org/10.1186/s13045-020-00984-1 3. Dinmohamed AG, Visser O, Verhoeven RHA, Louwman MWJ, van Nederveen FH, Willems SM, Merkx MAW, Lemmens V, Nagtegaal ID, Siesling S (2020b) Fewer cancer diagnoses during the COVID-19 epidemic in The Netherlands. Lancet Oncol 21:750–751. https://doi.org/10.1016/S1470-2045(20)30265-5 4. Erdmann F, Wellbrock M, Trubenbach C, Spix C, Schrappe M, Schuz J, Grabow D, Eichinger M (2021) Impact of the COVID-19 pandemic on incidence, time of diagnosis and delivery of healthcare among paediatric oncology patients in Germany in 2020: evidence from the German Childhood Cancer Registry and a qualitative survey. Lancet Reg Health Eur 9:100188. https://doi.org/10.1016/j.lanepe.2021.100188 5. Gasparri ML, Gentilini OD, Lueftner D, Kuehn T, Kaidar-Person O, Poortmans P (2020) Changes in breast cancer management during the Corona Virus Disease 19 pandemic: an international survey of the European Breast Cancer Research Association of Surgical Trialists (EUBREAST). Breast 52:110–115. https://doi.org/10.1016/j.breast.2020.05.006
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|